FrederickMSchnellMD

Oncology • Macon, GA

President of the Georgia Association of Clinical Oncologist.

Join to view full profile

Dr. Schnell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schnell's full profile

Already have an account?

Office
1300 Old Forsyth Road
Macon, Georgia
Macon, GA 31201
Phone+1 478-501-2808
Is this information wrong?

Education & Training

Emory University School of MedicineResidency, Internal Medicine, 1974 - 1977
Case Western Reserve University School of MedicineClass of 1974
Emory University School of MedicineFellowship, Hematology and Medical Oncology

Certifications & Licensure

AZ State Medical License 1980 - Present
GA State Medical License 1975 - 2025
OH State Medical License 1978 - 1984
TN State Medical License 1982 - 1983
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2005 May 01
Completed
Phase 3
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Start of enrollment: 2008 May 15
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct Start of enrollment: 2008 Dec 01
Completed
Phase 2
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2011 Jan 17
Completed
Phase 2
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
Completed
Phase 2
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 May 25
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
Completed
Phase 3
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lym...
Crump M, Leppä S, Fayad L, Lee JJ, Di Rocco A, Ogura M, Hagberg H, Schnell F, Rifkin R, Mackensen A, Offner F, Pinter-Brown L, Smith S, Tobinai K, Yeh S, Hsi ED, Nguye...> ;J. Clin. Oncol.. 2016-07-20
Final results from randomized phase II trial of preoperative docetaxel (D) and capecitabine (C) given sequentially or concurrently for HER2-negative breast cancers.
Zelnak AB, Harichand-Herdt S, Styblo TM, Rizzo M, Gabram SGA, Bumpers HL, Hermann RC, Srinivasiah J, Schnell FM, O'Regan R> ;J. Clin. Oncol.. 2011-05-20
Neoadjuvant dose-dense sequential biweekly epirubicin and cyclophosphamide followed by docetaxel and trastuzumab for HER2+ operable breast cancer.
Blakely L, Somer B, Keaton M, Hermann R, Schnell F, Cobb P, Johns A, Walker M, Schwartzberg L> ;J. Clin. Oncol.. 2009-05-20
Treatment (T) guideline (G) development and implementation (I) in community (COMM) practice (P): Experience of the cancer centers of excellence (CCE) network and its c...
Schnell FM, Bosserman LD, Ebrahimi B, Presant CA, Bergstrom K> ;J. Clin. Oncol.. 2008-05-20
Practice pattern for patients receiving secondline treatment for non-small cell lung cancer (NSCLC) with erlotinib in the community setting.
Blakely LJ, Schwartzberg LS, Stepanski EJ, Reyes C, Kapur D, Cobb PW, Schnell FM, Walker MS> ;J. Clin. Oncol.. 2008-05-20
Role of Palifermin in Fluorouracil-Based Therapy for Metastatic Colorectal Cancer
John Zalcberg, Lee S. Rosen, E Abdi, Ian D. Davis, John Gutheil, Frederick M. Schnell, Alessandra Cesano, Urte Gayko, Mon Gy Chen, Stephen Clarke> ;Journal of Clinical Oncology. 2008 Mar 10
79 citations
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy
Lee S. Rosen, Ehtesham Abdi, Ian D. Davis, John Gutheil, Frederick M. Schnell, John Zalcberg, Alessandra Cesano, Urte Gayko, Mon Gy Chen, Stephen Clarke> ;Journal of Clinical Oncology. 2006 Nov 20
Topotecan, paclitaxel, and carboplatin in advanced ovarian cancer: A phase II trial of the Minnie Pearl Cancer Research Network.
Zubkus JD, Hainsworth JD, Spigel DR, Patton JF, Shipley DL, Baskette M, Schnell F, Greco FA> ;J. Clin. Oncol.. 2006-06-20
Phase II trial of pemetrexed (P) and gemcitabine (G) as first-line chemotherapy for elderly and/or poor performance status patients with stage IIIB/IV non-small cell l...
Blakely J, Schnell F, Kaywin P, Keaton M, Fortner B, Epperson A, Schwartzberg LS> ;J. Clin. Oncol.. 2006-06-20
6 citations
Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: a Minnie Pearl Cancer Research Network Phase II trial.
John D. Hainsworth, Denise A. Yardley, David R. Spigel, A. A. Meluch, David Rinaldi, Frederick M. Schnell, F. Anthony Greco> ;Cancer Investigation. 2006 Jan 1
10 citations
An evaluation of potential signals for ventricular arrhythmia and cardiac arrest with dolasetron, ondansetron, and granisetron in the fda combined spontaneous reportin...
Frederick M. Schnell, Andrew J Coop> ;Current Therapeutic Research, Clinical and Experimental. 2005 Sep 1
Phase II trial of gemcitabine plus trastuzumab in minimally pretreated HER2 overexpressing metastatic breast cancer.
Peacock NW, Bearden J, Schnell F, White M, Greco FA, Burris HA, Barton JH, Hainsworth JD, Spigel DR, Yardley DA> ;J. Clin. Oncol.. 2005-06-01
Weekly docetaxel versus weekly docetaxel/gemcitabine as first-line therapy for patients who are elderly or with poor performance status (PS) or with serious comorbidit...
Mainwaring MG, Hainsworth JD, Spigel DR, Gray JR, Shipley DL, Morrissey LH, Greenwell S, Joseph G, Bradof JE, Schnell FM, Greco FA> ;J. Clin. Oncol.. 2005-06-01
40 citations
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
John D. Hainsworth, A. A. Meluch, Sharlene Litchy, Frederick M. Schnell, James D. Bearden, Kathleen Yost, F. Anthony Greco> ;Cancer. 2005 Jun 1
59 citations
Safety and Pain Palliation of Zoledronic Acid in Patients with Breast Cancer, Prostate Cancer, or Multiple Myeloma Who Previously Received Bisphosphonate Therapy
Charles L. Vogel, Ronald H. Yanagihara, Albert J. Wood, Frederick M. Schnell, Charles Henderson, Barry H. Kaplan, Malcolm H. Purdy, Richard Orlowski, Jodi L. Decker, L...> ;The Oncologist. 2004 Nov 1
Safety of zoledronic acid in patients who have previously received bisphosphonate therapy.
Yanagihara R, Vogel CL, Wood AJ, Schnell FM, Henderson C, Kaplan BH, Purdy MH, Orlowski R, Decker J, Lacerna L> ;J. Clin. Oncol.. 2004-07-15
141 citations
Chemotherapy-Induced Nausea and Vomiting: The Importance of Acute Antiemetic Control
Frederick M. Schnell> ;The Oncologist. 2003 Apr 1
11 citations
Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer
William H. West, Robert Birch, Frederick M. Schnell, John D. Hainsworth, Jose Tongol, Luis T. Campos> ;The Oncologist. 2003 Feb 1
17 citations
High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. A phase II trial of the Piedmont Oncology Association.
James N. Atkins, Hyman B. Muss, Douglas Case, J. Brockschmidt, Frederick M. Schnell, M A O'Rourke, T. H. Grote, J. H. West, S. Anthony, V. Stanley> ;American Journal of Clinical Oncology. 1991 Dec 1
3 citations
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study.
Douglas R. White, Bayard L. Powell, Craig Jb, Robert K. Stuart, Frederick M. Schnell, Gerald A. Goldklang, James N. Atkins, Don V. Jackson, Frederick Richards, Hyman B...> ;Cancer. 1990 Apr 15
1 citations
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association Study.
Bayard L. Powell, Craig Jb, Hyman B. Muss, Patricia J. Zekan, Cooper Mr, Frederick M. Schnell, Hampton Jw, Douglas R. White, Smith Lr, Robert L. Capizzi> ;American Journal of Clinical Oncology. 1988 Oct 1
Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell support.
Schwartzberg, L. S., Weaver, C. H., Birch, R., Giudice, R., Sobong, E., Schnell, F., Kalman, L., Buckner, C. D.> ;Am J Clin Oncol. 1999 Apr
A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer.
Blakely, L. J., Schwartzberg, L., Keaton, M., Schnell, F., Henry, D., Epperson, A., Walker, M. S.> ;Lung Cancer. 2009 Oct 01
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer.
Weaver, C. H., Schwartzberg, L. S., Birch, R., Greco, F. A., Hainsworth, J., Drapkin, R., Campos, L., Grapski, R., Schwerkoske, J., Lautersztain, J., Hazelton, B., Sch...> ;Biol Blood Marrow Transplant. 1997 Jun
Join now to see all

Press Mentions

With This Grant Renewal Comes New Initiatives and Grant Aims to Further Expand Cancer Research to a Broader Population and Include Underserved Populations in Cancer Research:July 16th, 2019
Geriatric Assessments Could Fine-Tune Cancer Care for Older AdultsJune 28th, 2018

Hospital Affiliations

Houston Medical CenterWarner Robins, Georgia
Atrium Health Navicent The Medical CenterMacon, Georgia
Piedmont MaconMacon, Georgia

FrederickMSchnellMD

Dr. Schnell is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.